Upstate Active Clinical Trials

Study Title:

ESTABLISHMENT OF A NATIONAL BIOREPOSITORY TO ADVANCE STUDIES OF IMMUNE-RELATED ADVERSE EVENTS

What is the purpose of the study? (in Layman's terms, please describe the study)

To establish a national biorepository including biospecimen and clinical data collections from patients treated with immuno-oncology (IO) therapeutics who experience one or more serious (grade 3-4) immune-related adverse events (irAEs), rare infections or hyperprogression (acceleration of tumor growth).

Upstate Institutional Review Board (IRB) Number:

1579273

Study/Protocol ID:

A151804

Study Phase:

N/A

Patient Age Group:

Adults

Principal Investigator:

Stephen L Graziano, MD

What is involved if I participate?

• How long is the study?
  1 year
• Is transportation provided or reimbursed?
  No
• Is parking provided or reimbursed?
  No
• What tests and procedures are involved?
  Tumor tissue and blood samples will be collected

Where will the study take place?

Upstate Cancer Center

Other Information:

N/A

ClinicalTrials.Gov ID:

NCT04242095

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: William Russell
Phone: 315-464-6971
Email: [email protected]

Return to Previous Page || Search Again